Scott P Kelly1, Barry I Graubard1, Gabriella Andreotti1, Naji Younes1, Sean D Cleary1, Michael B Cook1. 1. Affiliations of authors: Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD (SPK, BIG, GA, MBC); Department of Epidemiology and Biostatistics, Milken Institute School of Public Health, The George Washington University, Washington, DC (SPK, NY, SDC).
Abstract
Background: Evidence suggests that obesity in adulthood is associated with increased risk of "clinically significant" prostate cancer. However, studies of body mass index (BMI) across the adult life course and prostate cancer risks remain limited. Methods: In a prospective cohort of 69 873 men in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial, we examined associations of prediagnostic BMI across the adult life course with risk of incident prostate cancer and fatal prostate cancer (prostate cancer-specific mortality). At 13 years of follow-up, we identified 7822 incident prostate cancer cases, of which 3078 were aggressive and 255 fatal. BMI trajectories were determined using latent-class trajectory modeling. Cox proportional hazards regression was used to estimate hazard ratios (HRs) and 95% confidence intervals (CIs). Results: BMI at age 20 years, 50 years, and baseline questionnaire (mean age = 63 years) were associated with increased risks of fatal prostate cancer (HRs = 1.27-1.32 per five-unit increase). In five BMI trajectories identified, fatal prostate cancer risk was increased in men who had a normal BMI (HR = 1.95, 95% CI = 1.21 to 3.12) or who were overweight (HR = 2.65, 95% CI = 1.35 to 5.18) at age 20 years and developed obesity by baseline compared with men who maintained a normal BMI. Aggressive and nonaggressive prostate cancer were not associated with BMI, and modest inverse associations were seen for total prostate cancer. Conclusions: Our results suggest that BMI trajectories during adulthood that result in obesity lead to an elevated risk of fatal prostate cancer. Published by Oxford University Press 2016. This work is written by US Government employees and is in the public domain in the US.
RCT Entities:
Background: Evidence suggests that obesity in adulthood is associated with increased risk of "clinically significant" prostate cancer. However, studies of body mass index (BMI) across the adult life course and prostate cancer risks remain limited. Methods: In a prospective cohort of 69 873 men in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial, we examined associations of prediagnostic BMI across the adult life course with risk of incident prostate cancer and fatal prostate cancer (prostate cancer-specific mortality). At 13 years of follow-up, we identified 7822 incident prostate cancer cases, of which 3078 were aggressive and 255 fatal. BMI trajectories were determined using latent-class trajectory modeling. Cox proportional hazards regression was used to estimate hazard ratios (HRs) and 95% confidence intervals (CIs). Results: BMI at age 20 years, 50 years, and baseline questionnaire (mean age = 63 years) were associated with increased risks of fatal prostate cancer (HRs = 1.27-1.32 per five-unit increase). In five BMI trajectories identified, fatal prostate cancer risk was increased in men who had a normal BMI (HR = 1.95, 95% CI = 1.21 to 3.12) or who were overweight (HR = 2.65, 95% CI = 1.35 to 5.18) at age 20 years and developed obesity by baseline compared with men who maintained a normal BMI. Aggressive and nonaggressive prostate cancer were not associated with BMI, and modest inverse associations were seen for total prostate cancer. Conclusions: Our results suggest that BMI trajectories during adulthood that result in obesity lead to an elevated risk of fatal prostate cancer. Published by Oxford University Press 2016. This work is written by US Government employees and is in the public domain in the US.
Authors: Julie K Bassett; Gianluca Severi; Laura Baglietto; Robert J MacInnis; Hoa N Hoang; John L Hopper; Dallas R English; Graham G Giles Journal: Int J Cancer Date: 2012-02-28 Impact factor: 7.396
Authors: S O Andersson; J Baron; A Wolk; C Lindgren; R Bergström; H O Adami Journal: Cancer Epidemiol Biomarkers Prev Date: 1995 Apr-May Impact factor: 4.254
Authors: Elisabeth Möller; Kathryn M Wilson; Julie L Batista; Lorelei A Mucci; Katarina Bälter; Edward Giovannucci Journal: Int J Cancer Date: 2015-09-23 Impact factor: 7.396
Authors: Mari-Anne Rowlands; David Gunnell; Ross Harris; Lars J Vatten; Jeff M P Holly; Richard M Martin Journal: Int J Cancer Date: 2009-05-15 Impact factor: 7.396
Authors: Edward Giovannucci; Eric B Rimm; Yan Liu; Michael Leitzmann; Kana Wu; Meir J Stampfer; Walter C Willett Journal: J Natl Cancer Inst Date: 2003-08-20 Impact factor: 13.506
Authors: Scott P Kelly; Hannah Lennon; Matthew Sperrin; Charles Matthews; Neal D Freedman; Demetrius Albanes; Michael F Leitzmann; Andrew G Renehan; Michael B Cook Journal: Int J Epidemiol Date: 2019-04-01 Impact factor: 7.196
Authors: J M Genkinger; K Wu; M Wang; D Albanes; A Black; P A van den Brandt; K A Burke; M B Cook; S M Gapstur; G G Giles; E Giovannucci; G G Goodman; P J Goodman; N Håkansson; T J Key; S Männistö; L Le Marchand; L M Liao; R J MacInnis; M L Neuhouser; E A Platz; N Sawada; J M Schenk; V L Stevens; R C Travis; S Tsugane; K Visvanathan; L R Wilkens; A Wolk; S A Smith-Warner Journal: Ann Oncol Date: 2020-01 Impact factor: 32.976
Authors: Barbra A Dickerman; Thomas U Ahearn; Edward Giovannucci; Meir J Stampfer; Paul L Nguyen; Lorelei A Mucci; Kathryn M Wilson Journal: Int J Cancer Date: 2017-06-08 Impact factor: 7.396
Authors: Baiyu Yang; Jessica L Petrick; Scott P Kelly; Barry I Graubard; Neal D Freedman; Katherine A McGlynn Journal: Int J Cancer Date: 2017-04-26 Impact factor: 7.396
Authors: Britt W Jensen; Charlotte Watson; Nophar Geifman; Jennifer L Baker; Ellena Badrick; Andrew G Renehan Journal: Obes Facts Date: 2021-12-13 Impact factor: 4.807
Authors: Olivia Sattayapiwat; Peggy Wan; Brenda Y Hernandez; Loic Le Marchand; Lynne Wilkens; Christopher A Haiman Journal: Am J Epidemiol Date: 2021-09-01 Impact factor: 5.363
Authors: Lauren M Hurwitz; Edward D Yeboah; Richard B Biritwum; Yao Tettey; Andrew A Adjei; James E Mensah; Evelyn Tay; Vicky Okyne; Ann Truelove; Scott P Kelly; Cindy Ke Zhou; Eboneé N Butler; Robert N Hoover; Ann W Hsing; Michael B Cook Journal: Int J Cancer Date: 2020-05-06 Impact factor: 7.316